The Enterprise Value as of December 2025 (TTM) for Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) is 9.25B

According to Chengdu Easton Biopharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.25B. This represents a change of 44.47% compared to the average of 6.40B of the last 4 quarters.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Historical Enterprise Value (quarterly & annually)

How has 688513.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Chengdu Easton Biopharmaceuticals Co., Ltd. over the last ten years is 4.17B. The current 9.25B Enterprise Value has changed 22.08% with respect to the historical average. Over the past ten years (40 quarters), 688513.SS's Enterprise Value was at its highest in in the September 2025 quarter at 9.24B. The Enterprise Value was at its lowest in in the June 2015 quarter at 0.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Chengdu Easton Biopharmaceuticals Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Average Enterprise Value

How has 688513.SS Enterprise Value performed in the past?

The current Enterprise Value of Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) Enterprise Value vs. Peers

How is 688513.SS’s Enterprise Value compared to its peers?

Chengdu Easton Biopharmaceuticals Co., Ltd.’s Enterprise Value is greater than Shanghai Haohai Biological Technology Co., Ltd. (7.22B), less than Chengdu Kanghua Biological Products Co., Ltd. (9.55B), less than Aurisco Pharmaceutical Co.,Ltd. (9.48B), less than Anhui Huaheng Biotechnology Co., Ltd. (10.39B), greater than Zhejiang Ausun Pharmaceutical Co., Ltd. (7.41B), less than Zhejiang Jolly Pharmaceutical Co.,LTD (11.94B), less than Chengzhi Shareholding Co., Ltd. (13.78B), less than Chengdu Olymvax Biopharmaceuticals Inc. (11.41B), less than China Resources Boya Bio-pharmaceutical Group Co., Ltd. (11.44B), less than Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (14.40B),

Build a custom stock screener for Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chengdu Easton Biopharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chengdu Easton Biopharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.